ReviewJournal of diabetes2024

Recent drug development of dorzagliatin, a new glucokinase activator, with the potential to treat Type 2 diabetes: A review study.

Yu Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.